Table 3.
FAORs and EFW according to measured GW in the subjects subsequently diagnosed with NGT and GDM.
| NGTa | GDMb | p-value | |
|---|---|---|---|
| GA-AC/GA-LMP | |||
| 20–21 GW | 1.035 ± 0.039 | 1.042 ± 0.036 | 0.3688 |
| 21–22 GW | 1.030 ± 0.036 | 1.038 ± 0.037 | 0.0153 |
| 22–23 GW | 1.026 ± 0.037 | 1.034 ± 0.039 | 0.0093 |
| 23–24 GW | 1.018 ± 0.037 | 1.022 ± 0.036 | 0.4567 |
| GA-AC/GA-BPD | |||
| 20–21 GW | 1.017 ± 0.043 | 1.020 ± 0.041 | 0.7431 |
| 21–22 GW | 1.014 ± 0.042 | 1.021 ± 0.045 | 0.0717 |
| 22–23 GW | 1.012 ± 0.043 | 1.019 ± 0.042 | 0.0518 |
| 23–24 GW | 1.010 ± 0.043 | 1.017 ± 0.042 | 0.9459 |
| GA-AC/GA-FL | |||
| 20–21 GW | 1.029 ± 0.039 | 1.030 ± 0.034 | 0.8217 |
| 21–22 GW | 1.027 ± 0.040 | 1.035 ± 0.042 | 0.0252 |
| 22–23 GW | 1.022 ± 0.040 | 1.030 ± 0.045 | 0.0148 |
| 23–24 GW | 1.015 ± 0.041 | 1.023 ± 0.044 | 0.2025 |
| EFW (g) | |||
| 20–21 GW | 396.2 ± 50.8 | 406.3 ± 62.5 | 0.3138 |
| 21–22 GW | 460.3 ± 55.5 | 469.7 ± 50.5 | 0.0649 |
| 22–23 GW | 537.5 ± 63.3 | 544.9 ± 60.6 | 0.1643 |
| 23–24 GW | 620.2 ± 70.5 | 615.3 ± 61.1 | 0.6313 |
FAOR fetal abdominal overgrowth ratio, EFW estimated fetal weight, NGT normal glucose tolerance, GDM gestational diabetes mellitus, GW gestational week, GA-AC estimated gestational age by abdominal circumference, GA-LMP gestational age by last menstruation period, GA-BPD estimated gestational age by biparietal diameter, GA-FL estimated gestational age by femur length.
aNumber of NGT subjects having available data for FAORs and EFW at GW 20–21, 21–22, 22–23, and 23–24 were 486, 2344, 2688, and 951, respectively. bNumber of GDM subjects having available data for FAORs and EFW at GW 20–21, 21–22, 22–23, and 23–24 were 28, 124, 148, and 48, respectively.